These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR. Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [Abstract] [Full Text] [Related]
12. Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. Sapolsky AI, Keiser H, Howell DS, Woessner JF. J Clin Invest; 1976 Oct; 58(4):1030-41. PubMed ID: 9425 [Abstract] [Full Text] [Related]
13. Nitric oxide activates metalloprotease enzymes in articular cartilage. Murrell GA, Jang D, Williams RJ. Biochem Biophys Res Commun; 1995 Jan 05; 206(1):15-21. PubMed ID: 7529496 [Abstract] [Full Text] [Related]
14. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, Cole AA. Lab Invest; 1996 Jan 05; 74(1):232-40. PubMed ID: 8569187 [Abstract] [Full Text] [Related]
15. Mononuclear cell factors stimulate the concomitant secretion of distinct latent proteoglycan, gelatin and collagen degrading enzymes from human skin fibroblasts and synovial cells. Golds EE, Santer V, Killackey J, Roughley PJ. J Rheumatol; 1983 Dec 05; 10(6):861-71. PubMed ID: 6319695 [Abstract] [Full Text] [Related]
16. [Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis]. Mohamed-Ali H. Wien Med Wochenschr; 1991 Dec 05; 141(4):77-85. PubMed ID: 1645488 [Abstract] [Full Text] [Related]
17. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Yasuda T, Poole AR. Arthritis Rheum; 2002 Jan 05; 46(1):138-48. PubMed ID: 11817586 [Abstract] [Full Text] [Related]
18. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. Yamada H, Watanabe K, Saito T, Hayashi H, Niitani Y, Kikuchi T, Ito A, Fujikawa K, Lohmander LS. J Rheumatol; 1999 Mar 05; 26(3):654-62. PubMed ID: 10090178 [Abstract] [Full Text] [Related]
19. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR. Arthritis Rheum; 2000 Mar 05; 43(3):673-82. PubMed ID: 10728762 [Abstract] [Full Text] [Related]
20. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. Lum ZP, Hakala BE, Mort JS, Recklies AD. J Cell Physiol; 1996 Feb 05; 166(2):351-9. PubMed ID: 8591995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]